G220 150 (Lithium 150 mg)
Pill imprint G220 150 has been identified as Lithium carbonate 150 mg.
Lithium is used in the treatment of bipolar disorder; schizoaffective disorder; mania; intermittent explosive disorder; cyclothymic disorder (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 150 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for G220 150 (Lithium 150 mg)
- Imprint:
-
G220
150 - Strength:
- 150 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antipsychotic agents
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Glenmark Generics Inc.
- National Drug Code (NDC):
- 68462-0220
- Inactive Ingredients:
- FD&C Blue No. 1
FD&C Red No. 40
D&C Yellow No. 10
silicon dioxide
gelatin
sodium lauryl sulfate
magnesium silicate
titanium dioxide
shellac
isopropyl alcohol
alcohol
butyl alcohol
propylene glycol
ammonia
potassium hydroxide
ferrosoferric oxide
More resources
Lithium carbonate is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
